Ancora Advisors’s Halozyme HALO Stock Holding History

Ancora Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.85K	Hold	113	–	–	﹤0.01%	1505
2026 Q1	$7.3K	Hold	113	–	–	﹤0.01%	1865
2025 Q4	$7.61K	Hold	113	–	–	﹤0.01%	1860
2025 Q3	$8.29K	Hold	113	–	–	﹤0.01%	1416
2025 Q2	$5.88K	Buy	+113	New	+$6.43K	﹤0.01%	1464

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ancora Advisors's HALO Position: Q2 2026 in Review

Ancora Advisors held its Halozyme (HALO) position steady in Q2 2026 at 113 shares worth $8.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Ancora Advisors first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Ancora Advisors held 113 shares of Halozyme worth $8.85K as of Q2 2026.
Ancora Advisors left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1505 holding.
Ancora Advisors first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.